Notice: Prescription Drug List (PDL): Naloxone
The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-30
Data overview
- Formats
- HTML
- File languages
- English, French